These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24048258)

  • 1. A novel approach for developing and interpreting treatment moderator profiles in randomized clinical trials.
    Wallace ML; Frank E; Kraemer HC
    JAMA Psychiatry; 2013 Nov; 70(11):1241-7. PubMed ID: 24048258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach.
    Kraemer HC
    Stat Med; 2013 May; 32(11):1964-73. PubMed ID: 23303653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing Personalized Medicine: Application of a Novel Statistical Method to Identify Treatment Moderators in the Coordinated Anxiety Learning and Management Study.
    Niles AN; Loerinc AG; Krull JL; Roy-Byrne P; Sullivan G; Sherbourne CD; Bystritsky A; Craske MG
    Behav Ther; 2017 Jul; 48(4):490-500. PubMed ID: 28577585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder.
    Smagula SF; Wallace ML; Anderson SJ; Karp JF; Lenze EJ; Mulsant BH; Butters MA; Blumberger DM; Diniz BS; Lotrich FE; Dew MA; Reynolds CF
    J Psychiatr Res; 2016 Oct; 81():112-8. PubMed ID: 27438687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive transcranial magnetic stimulation (r-TMS) and selective serotonin reuptake inhibitor-resistance in obsessive-compulsive disorder: A meta-analysis and clinical implications.
    Pellegrini L; Garg K; Enara A; Gottlieb DS; Wellsted D; Albert U; Laws KR; Fineberg NA
    Compr Psychiatry; 2022 Oct; 118():152339. PubMed ID: 35917621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediators and moderators of treatment effects in randomized clinical trials.
    Kraemer HC; Wilson GT; Fairburn CG; Agras WS
    Arch Gen Psychiatry; 2002 Oct; 59(10):877-83. PubMed ID: 12365874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysis.
    Weitz ES; Hollon SD; Twisk J; van Straten A; Huibers MJ; David D; DeRubeis RJ; Dimidjian S; Dunlop BW; Cristea IA; Faramarzi M; Hegerl U; Jarrett RB; Kheirkhah F; Kennedy SH; Mergl R; Miranda J; Mohr DC; Rush AJ; Segal ZV; Siddique J; Simons AD; Vittengl JR; Cuijpers P
    JAMA Psychiatry; 2015 Nov; 72(11):1102-9. PubMed ID: 26397232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy.
    Frank E; Cassano GB; Rucci P; Thompson WK; Kraemer HC; Fagiolini A; Maggi L; Kupfer DJ; Shear MK; Houck PR; Calugi S; Grochocinski VJ; Scocco P; Buttenfield J; Forgione RN
    Psychol Med; 2011 Jan; 41(1):151-62. PubMed ID: 20380782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.
    Kendrick T; Chatwin J; Dowrick C; Tylee A; Morriss R; Peveler R; Leese M; McCrone P; Harris T; Moore M; Byng R; Brown G; Barthel S; Mander H; Ring A; Kelly V; Wallace V; Gabbay M; Craig T; Mann A
    Health Technol Assess; 2009 Apr; 13(22):iii-iv, ix-xi, 1-159. PubMed ID: 19401066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderators in psychotherapy meta-analysis.
    Spielmans GI; Flückiger C
    Psychother Res; 2018 May; 28(3):333-346. PubMed ID: 29313464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial to evaluate the effects of personalized prediction and adaptation tools on treatment outcome in outpatient psychotherapy: study protocol.
    Lutz W; Zimmermann D; Müller VNLS; Deisenhofer AK; Rubel JA
    BMC Psychiatry; 2017 Aug; 17(1):306. PubMed ID: 28836954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying a novel statistical method to advance the personalized treatment of anxiety disorders: A composite moderator of comparative drop-out from CBT and ACT.
    Niles AN; Wolitzky-Taylor KB; Arch JJ; Craske MG
    Behav Res Ther; 2017 Apr; 91():13-23. PubMed ID: 28110111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive-behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled trial.
    Goodyer IM; Reynolds S; Barrett B; Byford S; Dubicka B; Hill J; Holland F; Kelvin R; Midgley N; Roberts C; Senior R; Target M; Widmer B; Wilkinson P; Fonagy P
    Health Technol Assess; 2017 Mar; 21(12):1-94. PubMed ID: 28394249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis.
    Ray LA; Meredith LR; Kiluk BD; Walthers J; Carroll KM; Magill M
    JAMA Netw Open; 2020 Jun; 3(6):e208279. PubMed ID: 32558914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision medicine for long-term depression outcomes using the Personalized Advantage Index approach: cognitive therapy or interpersonal psychotherapy?
    van Bronswijk SC; DeRubeis RJ; Lemmens LHJM; Peeters FPML; Keefe JR; Cohen ZD; Huibers MJH
    Psychol Med; 2021 Jan; 51(2):279-289. PubMed ID: 31753043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
    Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
    Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of treatment outcomes in major depressive disorder.
    Dunlop BW
    Expert Rev Clin Pharmacol; 2015; 8(6):669-72. PubMed ID: 26289221
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.